Cannabis Bioscience International Holdings, Inc. (CBIH) stock
CBIHOTCServices-Commercial Physical & Biological ResearchFiscal year ends May 31
$0.00+0.00 (+33.33%)
Close on Oct 19, 2026Market cap $2.33MP/E –Yield –
Cannabis Bioscience International revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Cannabis Bioscience International's revenue for the twelve months ending Feb 28, 2026 was $123.63K, down 64.1% year over year. For fiscal 2025 it was $303.02K, up 21.8% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | May 31, 2025 | $303.02K | +21.8% |
| FY2024 | May 31, 2024 | $248.84K | -21.5% |
| FY2023 | May 31, 2023 | $316.83K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | $11.21K | -25.0% |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | $53.27K | -28.3% |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | $24.20K | -86.5% |
| Q4 FY2025CQ2 2025 | May 31, 2025 | $34.96K | -53.9% |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | $14.93K | -59.0% |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | $74.25K | +16.5% |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | $178.89K | +145.7% |
| Q4 FY2024CQ2 2024 | May 31, 2024 | $75.86K | +63.5% |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | $36.41K | -29.0% |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | $63.75K | -22.8% |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | $72.82K | – |
| Q4 FY2023CQ2 2023 | May 31, 2023 | $46.41K | – |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | $51.25K | – |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | $82.58K | – |
See a number that looks wrong?